Access cutting-edge cutaneous lupus erythematosus treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access cutaneous lupus erythematosus specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cutaneous lupus erythematosus treatment provided free
This study aims to evaluate the efficacy and safety of subcutaneous (SC) anifrolumab versus placebo in adult participants with cutaneous lupus erythematosus (CLE).
Sponsor: AstraZeneca
Check if you qualify for this cutaneous lupus erythematosus clinical trial in Phoenix, AZ
If you're searching for cutaneous lupus erythematosus treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cutaneous lupus erythematosus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.